Somatic and Germline BRCA 1 and 2 Mutations in Advanced NSCLC From the SAFIR02-Lung Trial

INTRODUCTION: Molecular profiling is considered a standard of care in advanced NSCLC. A comprehensive next-generation sequencing panel can discover somatic or germline BRCA1/2 mutations that are new druggable molecular alterations. However, the phenotypic and potential therapeutic relevance of BRCA1...

Descripción completa

Detalles Bibliográficos
Autores principales: Remon, Jordi, Besse, Benjamin, Leary, Alexandra, Bièche, Ivan, Job, Bastien, Lacroix, Ludovic, Auguste, Aurélie, Mauduit, Marjorie, Audigier-Valette, Clarisse, Raimbourg, Judith, Madroszyk, Anne, Michels, Stefan, Bayar, Mohammed Amine, Jimenez, Marta, Soria, Jean-Charles, Rouleau, Etienne, Barlesi, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474245/
https://www.ncbi.nlm.nih.gov/pubmed/34589950
http://dx.doi.org/10.1016/j.jtocrr.2020.100068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474245/
https://www.ncbi.nlm.nih.gov/pubmed/34589950
http://dx.doi.org/10.1016/j.jtocrr.2020.100068

Ejemplares similares